
Medacta Group SA
SIX:MOVE

Intrinsic Value
The intrinsic value of one
MOVE
stock under the Base Case scenario is
113.34
CHF.
Compared to the current market price of 129.2 CHF,
Medacta Group SA
is
Overvalued by 12%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Medacta Group SA
Fundamental Analysis


Revenue & Expenses Breakdown
Medacta Group SA
Balance Sheet Decomposition
Medacta Group SA
Current Assets | 364.3m |
Cash & Short-Term Investments | 21.7m |
Receivables | 118.4m |
Other Current Assets | 224.2m |
Non-Current Assets | 367.5m |
Long-Term Investments | 892k |
PP&E | 291.7m |
Intangibles | 49.7m |
Other Non-Current Assets | 25.2m |
Free Cash Flow Analysis
Medacta Group SA
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
Medacta Group SA
Revenue
|
544.3m
EUR
|
Cost of Revenue
|
-174.6m
EUR
|
Gross Profit
|
369.7m
EUR
|
Operating Expenses
|
-291.8m
EUR
|
Operating Income
|
78m
EUR
|
Other Expenses
|
-21.8m
EUR
|
Net Income
|
56.2m
EUR
|
MOVE Profitability Score
Profitability Due Diligence
Medacta Group SA's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Score
Medacta Group SA's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
MOVE Solvency Score
Solvency Due Diligence
Medacta Group SA's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Score
Medacta Group SA's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MOVE Price Targets Summary
Medacta Group SA
According to Wall Street analysts, the average 1-year price target for
MOVE
is 151.16 CHF
with a low forecast of 137.36 CHF and a high forecast of 168 CHF.
Dividends
Current shareholder yield for MOVE is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MOVE
stock under the Base Case scenario is
113.34
CHF.
Compared to the current market price of 129.2 CHF,
Medacta Group SA
is
Overvalued by 12%.